Lamequick CE 7203 deliciously creamy textures with non- hydrogenated fats

Consumers today expect dessert ingredients to be convenient to use and deliver a pleasant eating experience. They want creamy cake fillings that remain light and stable for a long time under a variety of conditions, and mousses and other aerated desserts that have the right volume, a firm texture, and a pleasant mouth feel. The Lamequick® whipping agents from Cognis Nutrition & Health already fulfill all of these demands, but these days, health considerations are also becoming increasingly important in these kinds of applications. In response to this trend, Cognis has developed an emulsifier system that makes possible the use of non-hydrogenated fats in whipping agents. This system forms the basis of Lamequick CE 7203, a new whipping agent whose excellent performance, ease of use and health benefits are fast establishing it as the preferred choice of many food manufacturers.

Lamequick CE 7203 is a whipping agent based on non-hydrogenated fats. It offers functional benefits such as high foam volume and good stability, is very user-friendly thanks to its consistent performance across the entire temperature range, and, being based on non hydrogenated fats, it also allows consumer-friendly claims. The product is suitable for most applications, especially decorative and filling creams for cakes, mousse-like or frozen desserts, and Italian-style or soft serve ice creams.

Superior results under a wide range of conditions
Cognis’ product tests have shown that Lamequick CE 7203 delivers good foam volume and firmness throughout the temperature range 5–25°C, meaning that products incorporating Lamequick CE 7203 are very convenient to use. Cake filling and decorating creams with the new whipping agent are firm and stable. They exhibit excellent freeze-thaw stability, and can hold complex shapes. Even after two days’ storage at 20°C, they remain free from surface cracks, and retain almost the same level of sliceability as they do after two days in the refrigerator. In aerated desserts like mousses, creams or tiramisu, Lamequick CE 7203 significantly enhances foam volume and firmness, and gives a very pleasant mouth feel. For Italian-style artisan ice cream, stability is a high priority. Lamequick CE 7203 yields very good results here as well: it slows melting significantly compared to conventional whipping agents.

A unique combination of performance, convenience and customer-friendliness
The development of Lamequick CE 7203 is the result of Cognis’ strategy of focusing on convenience, product performance and wellness. Says Friedrich Kielmeyer, Product Group Manager Food Ingredients: “We have developed a deep understanding of the needs of our customers operating in the food industry. Cognis Nutrition & Health is able to offer a regular stream of product innovations on the basis of decades of experience in food technology, and specifically in the processing of high-quality raw materials. This unique combination of performance and market insight means that Cognis customers who use Lamequick CE 7203 will gain a real competitive edge in a market that caters for health conscious consumers.”

About Cognis
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals.

Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.